BenevolentAI is an AI-powered drug discovery company that uses its biomedical knowledge graph and machine learning to identify novel disease targets and drug candidates across multiple therapeutic areas. It has an internal drug pipeline and provides platform access to pharmaceutical partners.

    Category

    Healthcare

    Subcategory

    Drug Discovery

    // ACCESS METHODS

    Web App

    // COMPLIANCE

    SOC2ISO27001GDPRHIPAA

    ● certified · ○ not verified

    // DATA STORAGE

    Region

    Trains on Data

    Self-hostable

    No

    // PRICING DETAIL

    Free Tier

    Not available yet

    Paid Plans

    Pharma partnership licensing

    API Cost

    Not available yet
    >> OPEN TOOL

    // MORE IN DRUG DISCOVERY

    R
    Recursion Pharmaceuticals
    Paid
    HealthcareDrug Discovery
    #drug discovery#machine learning#biology
    I
    Insilico Medicine
    Paid
    HealthcareDrug Discovery
    #drug discovery#generative ai#molecular design
    A
    Atomwise
    Paid
    HealthcareDrug Discovery
    #drug discovery#molecular modeling#deep learning

    // USE CASES

    Discovering novel drug targets from scientific literature miningPredicting drug repurposing opportunities for rare diseasesPharmaceutical partnerships for target validationEarly-stage drug pipeline development in oncology and neurodegenerationBuilding biomedical knowledge graphs for drug discovery